These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31095969)

  • 21. Matrix metalloproteinases and their inhibitors in acute viral hepatitis.
    Koulentaki M; Valatas V; Xidakis K; Kouroumalis A; Petinaki E; Castanas E; Kouroumalis E
    J Viral Hepat; 2002 May; 9(3):189-93. PubMed ID: 12010506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MMPs/TIMPs imbalances in the peripheral blood and cerebrospinal fluid are associated with the pathogenesis of HIV-1-associated neurocognitive disorders.
    Xing Y; Shepherd N; Lan J; Li W; Rane S; Gupta SK; Zhang S; Dong J; Yu Q
    Brain Behav Immun; 2017 Oct; 65():161-172. PubMed ID: 28487203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic changes of matrix metalloproteinases and their tissue inhibitors in severe sepsis.
    Mühl D; Nagy B; Woth G; Falusi B; Bogár L; Weber G; Lantos J
    J Crit Care; 2011 Dec; 26(6):550-5. PubMed ID: 21530151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Sedentary Aging and Lifelong Exercise on Left Ventricular Systolic Function.
    Howden EJ; Carrick-Ranson G; Sarma S; Hieda M; Fujimoto N; Levine BD
    Med Sci Sports Exerc; 2018 Mar; 50(3):494-501. PubMed ID: 29077636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease.
    Briasoulis A; Tousoulis D; Papageorgiou N; Kampoli AM; Androulakis E; Antoniades C; Tsiamis E; Latsios G; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1214-21. PubMed ID: 22519451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints.
    Takei I; Takagi M; Santavirta S; Ida H; Hamasaki M; Ishii M; Fukushima S; Ogino T; Konttinen YT
    J Biomed Mater Res; 1999 Jun; 45(3):175-83. PubMed ID: 10397973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of lifelong exercise dose on cardiovascular function during exercise.
    Carrick-Ranson G; Hastings JL; Bhella PS; Fujimoto N; Shibata S; Palmer MD; Boyd K; Livingston S; Dijk E; Levine BD
    J Appl Physiol (1985); 2014 Apr; 116(7):736-45. PubMed ID: 24458750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcifying Cystic Odontogenic Tumour: immunohistochemical expression of matrix metalloproteinases, their inhibitors (TIMPs and RECK) and inducer (EMMPRIN).
    Prosdócimi FC; Rodini CO; Sogayar MC; Sousa SC; Xavier FC; Paiva KB
    J Oral Pathol Med; 2014 Aug; 43(7):545-53. PubMed ID: 24484176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure.
    Wilson EM; Gunasinghe HR; Coker ML; Sprunger P; Lee-Jackson D; Bozkurt B; Deswal A; Mann DL; Spinale FG
    J Card Fail; 2002 Dec; 8(6):390-8. PubMed ID: 12528092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Investigation of Matrix Metalloproteinases, Tissue Inhibitors of Matrix Metalloproteinases, and Matrix Metalloproteinase/Tissue Inhibitors of Matrix Metalloproteinase Complexes and Their Networks in Apical Periodontitis.
    Martinho FC; Teixeira FF; Cardoso FG; Ferreira NS; Nascimento GG; Carvalho CA; Valera MC
    J Endod; 2016 Jul; 42(7):1082-8. PubMed ID: 27188765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives.
    Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
    Clin Chem Lab Med; 2004 Feb; 42(2):121-31. PubMed ID: 15061349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, aminoterminal propeptide of procollagen type III, and hyaluronan in sera and tissue of patients with capsular contracture after augmentation with Trilucent breast implants.
    Ulrich D; Lichtenegger F; Eblenkamp M; Repper D; Pallua N
    Plast Reconstr Surg; 2004 Jul; 114(1):229-36. PubMed ID: 15220598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloproteinases and left ventricular function and structure in spinal cord injured subjects.
    Schreiber R; Paim LR; de Rossi G; Matos-Souza JR; Costa E Silva Ade A; Souza CM; Borges M; Azevedo ER; Alonso KC; Gorla JI; Cliquet A; Nadruz W
    Clin Chim Acta; 2014 Nov; 437():136-40. PubMed ID: 25064800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix metalloproteinases and the activity of their tissue inhibitors in patients with ST-elevation myocardial infarction treated with primary angioplasty.
    Kuliczkowski W; Urbaniak J; Hallén J; Woźniak M; Poloński L; Mysiak A; Atar D; Zembala M; Serebruany V
    Kardiol Pol; 2013; 71(5):453-63. PubMed ID: 23788085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Serum interleukin 6 (il-6A) concentration correlates with matrix metalloproteinases and their tissue inhibitors in rheumatoid arthritis].
    Klimiuk PA; Sierakowski S; Chwiećko J
    Pol Arch Med Wewn; 2003 Feb; 109(2):119-23. PubMed ID: 12879774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of choline treatment in concentrations of serum matrix metalloproteinases (MMPs), MMP tissue inhibitors (TIMPs) and immunoglobulins in an experimental model of canine sepsis.
    Kocaturk M; Eralp-Inan O; Tvarijonaviciute A; Cansev M; Ozyigit MO; Ceron JJ; Yilmaz Z; Kahraman MM
    Vet Immunol Immunopathol; 2016 Nov; 180():9-14. PubMed ID: 27692098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Age-related dynamics of the contents of matrix metalloproteinases (MMP-1, -2, -3, -9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, -2, -4) in blood plasma of residents of the European part of the Arctic zone of the Russian Federation.].
    Kim LB; Russkih GS; Putyatina AN; Tsypysheva OB
    Adv Gerontol; 2018; 31(2):223-230. PubMed ID: 30080329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MMPs and TIMPs levels are correlated with anthropometric parameters, blood pressure, and endothelial function in obesity.
    Boumiza S; Chahed K; Tabka Z; Jacob MP; Norel X; Ozen G
    Sci Rep; 2021 Oct; 11(1):20052. PubMed ID: 34625635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conjunctival matrix metalloproteinases and their inhibitors in glaucoma patients.
    Helin-Toiviainen M; Rönkkö S; Puustjärvi T; Rekonen P; Ollikainen M; Uusitalo H
    Acta Ophthalmol; 2015 Mar; 93(2):165-71. PubMed ID: 25312247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer.
    Komorowski J; Pasieka Z; Jankiewicz-Wika J; Stepień H
    Thyroid; 2002 Aug; 12(8):655-62. PubMed ID: 12225633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.